Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3′-kinase/protein kinase B/mammalian target of rapamycin pathway

Liver hepatocellular carcinoma (LIHC) is the most common type, comprising 75–85% of all liver malignancies. We investigated the roles of cleavage stimulation factor 2 (CSTF2) in LIHC and explored the underlying mechanisms. CSTF2 expression and its association with LIHC patient survival probability w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng-Hui, Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161829/
https://www.ncbi.nlm.nih.gov/pubmed/35412944
http://dx.doi.org/10.1080/21655979.2022.2063100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161829/
https://www.ncbi.nlm.nih.gov/pubmed/35412944
http://dx.doi.org/10.1080/21655979.2022.2063100

Ejemplares similares